Literature DB >> 25326868

Reconstruction of multiple myeloma lesions around the pelvis and acetabulum.

Vasileios I Sakellariou1, Andreas F Mavrogenis, Olga Savvidou, Franklin H Sim, Panayiotis J Papagelopoulos.   

Abstract

Multiple myeloma is a malignancy of monoclonal plasma cells (plasma cells are of B-lymphocyte lineage of the hematopoietic system). It is the second most prevalent blood malignancy after non-Hodgkin's lymphoma. It accounts for approximately 1 % of all malignancies and 2 % of all cancer deaths. Bony involvement is very common; the incidence of pelvic and periacetabular involvement in MM is reported to be around 6 %. Lytic lesions comprise a hallmark of multiple myeloma, which may be complicated with pathologic fractures in a substantial percentage of patients. Pelvic and periacetabular bony involvement of multiple myeloma is associated with some unique characteristics regarding the biomechanics of this specific anatomical region, the morbidity, the overall survival, and prognosis, which all reflect to impairment of quality of life. In this paper, we review the special features of multiple myeloma lesions around the pelvis and acetabulum and present an algorithm of management with the use of current surgical techniques.

Entities:  

Mesh:

Year:  2014        PMID: 25326868     DOI: 10.1007/s00590-014-1555-4

Source DB:  PubMed          Journal:  Eur J Orthop Surg Traumatol        ISSN: 1633-8065


  55 in total

Review 1.  [Myeloma bone disease and RANKL signaling].

Authors:  Masahiro Abe
Journal:  Clin Calcium       Date:  2011-08

2.  International staging system for multiple myeloma.

Authors:  Philip R Greipp; Jesus San Miguel; Brian G M Durie; John J Crowley; Bart Barlogie; Joan Bladé; Mario Boccadoro; J Anthony Child; Herve Avet-Loiseau; Jean-Luc Harousseau; Robert A Kyle; Juan J Lahuerta; Heinz Ludwig; Gareth Morgan; Raymond Powles; Kazuyuki Shimizu; Chaim Shustik; Pieter Sonneveld; Patrizia Tosi; Ingemar Turesson; Jan Westin
Journal:  J Clin Oncol       Date:  2005-04-04       Impact factor: 44.544

3.  Plasmacytoma relapses in the absence of systemic progression post-high-dose therapy for multiple myeloma.

Authors:  Evangelos Terpos; Katayoun Rezvani; Supratik Basu; Alison E Milne; Peter E Rose; Geoffrey L Scott; Amin Rahemtulla; Diana Samson; Jane F Apperley
Journal:  Eur J Haematol       Date:  2005-11       Impact factor: 2.997

4.  Palliative radiotherapy in patients with multiple myeloma.

Authors:  M P Yaneva; V Goranova-Marinova; St Goranov
Journal:  J BUON       Date:  2006 Jan-Mar       Impact factor: 2.533

5.  Scintigraphy with technetium-99m methoxyisobutylisonitrile in multiple myeloma patients: correlation with the International Staging System.

Authors:  John Koutsikos; Vasiliki Grigoraki; Theodoros Athanasoulis; Antigoni Velidaki; Charalampos Mamoulakis; Athanasios Zomas; Nikos Anagnostopoulos; Evangelos Georgiou; Meletios Athanasios Dimopoulos; Cherry Zerva
Journal:  Hell J Nucl Med       Date:  2006 Sep-Dec       Impact factor: 1.102

6.  Multiple myeloma in younger age.

Authors:  Kalsoom Akhtar; Naeem Ahmed Laghari; Anwar Ul Haq; Muhammad Anees; Saif Ur Rehman; Mohammad Iftikhar Alam
Journal:  J Coll Physicians Surg Pak       Date:  2009-01       Impact factor: 0.711

7.  Classification and management of acetabular abnormalities in total hip arthroplasty.

Authors:  J A D'Antonio; W N Capello; L S Borden; W L Bargar; B F Bierbaum; W G Boettcher; M E Steinberg; S D Stulberg; J H Wedge
Journal:  Clin Orthop Relat Res       Date:  1989-06       Impact factor: 4.176

Review 8.  Insight opinion to surgically treated metastatic bone disease: Scandinavian Sarcoma Group Skeletal Metastasis Registry report of 1195 operated skeletal metastasis.

Authors:  Maire Ratasvuori; Rikard Wedin; Johnny Keller; Markus Nottrott; Olga Zaikova; Peter Bergh; Anders Kalen; Johan Nilsson; Halldor Jonsson; Minna Laitinen
Journal:  Surg Oncol       Date:  2013-04-04       Impact factor: 3.279

Review 9.  International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders.

Authors:  A Dispenzieri; R Kyle; G Merlini; J S Miguel; H Ludwig; R Hajek; A Palumbo; S Jagannath; J Blade; S Lonial; M Dimopoulos; R Comenzo; H Einsele; B Barlogie; K Anderson; M Gertz; J L Harousseau; M Attal; P Tosi; P Sonneveld; M Boccadoro; G Morgan; P Richardson; O Sezer; M V Mateos; M Cavo; D Joshua; I Turesson; W Chen; K Shimizu; R Powles; S V Rajkumar; B G M Durie
Journal:  Leukemia       Date:  2008-11-20       Impact factor: 11.528

Review 10.  Primary prevention of venous thromboembolism in medical and surgical oncology patients.

Authors:  A Stanley; A Young
Journal:  Br J Cancer       Date:  2010-04-13       Impact factor: 7.640

View more
  3 in total

1.  Extensive Remineralization of Large Pelvic Lytic Lesions Following Total Therapy Treatment in Patients With Multiple Myeloma.

Authors:  Meera Mohan; Rohan S Samant; Donghoon Yoon; Amy F Buros; Antonio Branca; Corey O Montgomery; Richard Nicholas; Larry J Suva; Roy Morello; Sharmilan Thanendrarajan; Carolina Schinke; Shmuel Yaccoby; Frits van Rhee; Faith E Davies; Gareth J Morgan; Maurizio Zangari
Journal:  J Bone Miner Res       Date:  2017-03-27       Impact factor: 6.741

2.  Joint-sparing reconstruction for extensive periacetabular metastases: Literature review and a novel minimally invasive surgical technique.

Authors:  Karla Teresa S Araneta; Maroun Rizkallah; Louis-Martin Boucher; Robert E Turcotte; Ahmed Aoude
Journal:  J Bone Oncol       Date:  2022-04-06       Impact factor: 4.491

3.  Total Hip Arthroplasty with a Cementless Acetabular Component and Impaction Bone Grafting for Dysplastic Osteoarthritis Complicated by Multiple Myeloma.

Authors:  Ryo Ogawa; Maki Hirao; Taro Umezu; Shigeru Yanagimoto
Journal:  Case Rep Orthop       Date:  2022-02-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.